- Home
- ACLX vs BGC Comparison
ACLX vs BGC Comparison
Compare ACLX & BGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ACLX | BGC |
|---|---|---|
| Founded | 2015 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2022 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ACLX | BGC |
|---|---|---|
| Price | $114.46 | $9.33 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $115.85 | $14.50 |
| AVG Volume (30 Days) | ★ 3.5M | 2.3M |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | ★ 0.84% |
| EPS Growth | N/A | ★ 24.00 |
| EPS | N/A | ★ 0.31 |
| Revenue | $22,286,000.00 | ★ $2,941,460,000.00 |
| Revenue This Year | $329.40 | $18.89 |
| Revenue Next Year | $151.37 | $7.83 |
| P/E Ratio | ★ N/A | $30.66 |
| Revenue Growth | N/A | ★ 29.99 |
| 52 Week Low | $47.86 | $7.24 |
| 52 Week High | $114.65 | $10.96 |
Technical Indicators
Market Signals| Indicator | ACLX | BGC |
|---|---|---|
| Relative Strength Index (RSI) | 83.82 | 49.13 |
| Support Level | $64.61 | $9.10 |
| Resistance Level | N/A | $9.82 |
| Average True Range (ATR) | 1.13 | 0.31 |
| MACD | 2.30 | -0.02 |
| Stochastic Oscillator | 99.34 | 20.35 |
Price Performance
Historical ComparisonAbout ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
About BGC BGC Group Inc.
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.